Israeli-Italian Life Sciences Investment Forum
Tel Aviv, Israel - June 10 2013
Biotechnologies & Healthcare
On June 10, during the international ILSI Biomed conference in Tel Aviv, Intesa Sanpaolo and Matimop will co-host the first Israeli-Italian Life Sciences Investment Forum. 8 early-stage life science startups from Israel and Italy will have the chance to pitch in front of an audience of international investors.
The event is backed by the Embassy of Italy in Tel Aviv, ICE (the Italian Trade Commission), the Italian/Israeli Chamber of Commerce, the Enterprise Europe Network and ISERD.
Among the keynote speakers are His Excellency Francesco Maria Talò, Ambassador of Italy to Israel and Mr. Marcel Shaton, General Manager of ISERD. Our partners from Assobiotec and Assobiomedica will also introduce their activities.
- The new generation of leads for neuromodulation (NM) for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
- Our business is focused on the production of innovative
supports for massive tissue regeneration and cell expansion
- Discovery, characterization and development of new antibiotics andother bioactive molecules for multiple indications from microbial strains